BIOPHARMCATALYST

Serial Number 90037875
Registration 6496435
700

Registration Progress

Application Filed
Jul 6, 2020
Under Examination
Approved for Publication
Jul 13, 2021
Published for Opposition
Jul 13, 2021
Registered
Sep 28, 2021

Basic Information

Serial Number
90037875
Registration Number
6496435
Filing Date
July 6, 2020
Registration Date
September 28, 2021
Published for Opposition
July 13, 2021
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Sep 28, 2021
Registration
Registered
Classes
035 036 042

Rights Holder

ASSAY DEPOT INC.

03
Address
29 S Hwy 101, Ste 230
Solana Beach, CA 92075

Ownership History

HIROSHI MANAGEMENT LIMITED

Original Applicant
99
Halswell Christchurch NZ

HIROSHI MANAGEMENT LIMITED

Owner at Publication
99
Halswell Christchurch NZ

ASSAY DEPOT INC.

New Owner After Publication #1
03
SOLANA BEACH, CA

ASSAY DEPOT INC.

Original Registrant
03
Solana Beach, CA

Legal Representation

Attorney
Pollie Gautsch, Esq.

USPTO Deadlines

Next Deadline
811 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-09-28)
Due Date
September 28, 2027
Grace Period Ends
March 28, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

33 events
Date Code Type Description
Dec 23, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 23, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 23, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 23, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 23, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 28, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER
Aug 4, 2021 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jul 29, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 29, 2021 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jul 29, 2021 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 29, 2021 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 13, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 13, 2021 PUBO A PUBLISHED FOR OPPOSITION
Jun 23, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 9, 2021 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 8, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 8, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 3, 2021 ALIE A ASSIGNED TO LIE
Mar 5, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 2, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 2, 2020 GNRT O NON-FINAL ACTION E-MAILED
Dec 2, 2020 CNRT R NON-FINAL ACTION WRITTEN
Dec 2, 2020 AMPX O PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Nov 18, 2020 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED
Nov 12, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 11, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 11, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 20, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 20, 2020 GNRT F NON-FINAL ACTION E-MAILED
Oct 20, 2020 CNRT R NON-FINAL ACTION WRITTEN
Oct 13, 2020 DOCK D ASSIGNED TO EXAMINER
Aug 3, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 9, 2020 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 035
Compiling indexes of information relevant to financial investment decisions
Class 036
Providing stock market information; financial analysis and information services; financial analysis and information services, namely, providing information to investors about the timing of the results of clinical trials for pharmaceuticals to aid investors in making financial investment decisions; providing investors with financial information relevant to financial investment decisions; information, advisory, consultancy and research services relating to finance and investments; providing financial analysis of pharmaceutical companies listed on the U.S. stock market, for investment purposes; providing financial analysis of pharmaceutical companies listed on the U.S. stock market, for research purposes; providing investment information relating to pharmaceutical development; any of the aforementioned services when provided via a website or via a newsletter
Class 042
Providing medical and scientific research information about the results of clinical trials for pharmaceuticals; analysis of technical pharmaceutical research data; provision of information and data relating to medical and veterinary research and development; providing information relating to pharmaceutical development including the results of clinical trials and pending clinical trial data of ongoing trials, for research purposes; any of the aforementioned services when provided via a website or via a newsletter

Classification

International Classes
035 036 042